Market Tracker

08/28 6:01pm ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

18.41
Delayed Data
As of Aug 28
 +0.37 / +2.05%
Today’s Change
7.51
Today|||52-Week Range
25.25
+90.78%
Year-to-Date

Today’s Trading

Previous close18.04
Today’s open17.86
Day’s range17.84 - 18.55
Volume1,285,045
Average volume (3 months)1,553,136
Market cap$2.4B
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+24.32%
Earnings growth (this year)+20.37%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.47%
P/E ratioNM
Price/Sales15.72
Price/Book55.97

Competitors

 Today’s
change
Today’s
% change
KITEKite Pharma Inc+1.38+2.53%
RDUSRadius Health Inc+0.70+1.11%
MCRBSeres Therapeutics I...+0.53+1.31%
OPHTOphthotech Corp+0.05+0.11%
Data as of 3:59pm ET, 08/28/2015

Financials

Next reporting dateNovember 9, 2015
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$75.3M
Annual profit (last year)-$68.4M
Net profit margin-90.76%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts